High-strength cannabis linked to addiction and mental health problems

High-strength cannabis linked to addiction and mental health problems: Largest ever study into the health effects of different types of cannabis highlights concerns about stronger forms of the drug. As the strength or potency of cannabis products has increased internationally over the years, so have rates of people being treated for cannabis addiction, say the […]

Read More… from High-strength cannabis linked to addiction and mental health problems

High-strength cannabis linked to addiction and mental health problems

High-strength cannabis linked to addiction and mental health problems: Largest ever study into the health effects of different types of cannabis highlights concerns about stronger forms of the drug. As the strength or potency of cannabis products has increased internationally over the years, so have rates of people being treated for cannabis addiction, say the […]

Read More… from High-strength cannabis linked to addiction and mental health problems

WHO recommendation for HIV prevention

WHO recommends long-acting cabotegravir for HIV prevention: New WHO guidelines advise countries to deliver long-acting cabotegravir as part of comprehensive approach to HIV prevention. WHO today released new guidelines for the use of long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV and called for countries to consider this safe and highly effective prevention […]

Read More… from WHO recommendation for HIV prevention

WHO recommendation for HIV prevention

WHO recommends long-acting cabotegravir for HIV prevention: New WHO guidelines advise countries to deliver long-acting cabotegravir as part of comprehensive approach to HIV prevention. WHO today released new guidelines for the use of long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV and called for countries to consider this safe and highly effective prevention […]

Read More… from WHO recommendation for HIV prevention

How does stress affect the eyes?

How does stress affect the eyes? It’s well known that excess stress can have physical long-term effects as well as mental ones. There are certain short-term symptoms that we’re all familiar with, such as clammy palms and quickened breathing, but did you know that one of the things stress can impact is your vision? What […]

Read More… from How does stress affect the eyes?

How does stress affect the eyes?

How does stress affect the eyes? It’s well known that excess stress can have physical long-term effects as well as mental ones. There are certain short-term symptoms that we’re all familiar with, such as clammy palms and quickened breathing, but did you know that one of the things stress can impact is your vision? What […]

Read More… from How does stress affect the eyes?

COVID vaccine patch fights variants better then needles

A needle-free vaccine patch could better fight COVID-19 variants, such as Omicron and Delta, than a traditional needle vaccine according to a University of Queensland study in mice. The research, conducted in partnership with Brisbane biotechnology company Vaxxas, tested the Hexapro SARS-CoV-2 spike vaccine using the Vaxxas high-density microarray patch (HD-MAP) technology, and the results […]

Read More… from COVID vaccine patch fights variants better then needles

COVID vaccine patch fights variants better then needles

A needle-free vaccine patch could better fight COVID-19 variants, such as Omicron and Delta, than a traditional needle vaccine according to a University of Queensland study in mice. The research, conducted in partnership with Brisbane biotechnology company Vaxxas, tested the Hexapro SARS-CoV-2 spike vaccine using the Vaxxas high-density microarray patch (HD-MAP) technology, and the results […]

Read More… from COVID vaccine patch fights variants better then needles

Protection still high six months after second dose

Pfizer-BioNTech and AstraZeneca vaccines offer high protection against severe COVID-19, six months after second doses, study finds. Protection against severe COVID-19 by two doses of Pfizer-BioNTech and AstraZeneca COVID-19 vaccines remained high up to six months after second doses, finds new research which analysed NHS health record data on over seven million adults. Reassuringly, the […]

Read More… from Protection still high six months after second dose

Protection still high six months after second dose

Pfizer-BioNTech and AstraZeneca vaccines offer high protection against severe COVID-19, six months after second doses, study finds. Protection against severe COVID-19 by two doses of Pfizer-BioNTech and AstraZeneca COVID-19 vaccines remained high up to six months after second doses, finds new research which analysed NHS health record data on over seven million adults. Reassuringly, the […]

Read More… from Protection still high six months after second dose